Skip to main content

Table 2 Genotyping results of rs12696304 and rs2736100 in controls and patients with GN/CKD/ESRD

From: The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females

 

Controls (M + F)

Patients

(M + F)

Odds ratio

(95% CI)

P value

Controls (M only)

Patients

(M only)

Odds ratio

(95% CI)

P value

Controls

(F only)

Patients

(F only)

Odds ratio

(95% CI)

P

value

rs12696304 (N)

515 (100%)

759 (100%)

  

289 (100%)

434 (100%)

  

226(100%)

326(100%)

  

CC

56 (10.9)

64 (8.4)

1.0 (ref.)

 

32 (11.1)

40 (9.2)

1.0 (ref.)

 

24 (10.6)

24 (7.4)

1.0 (ref.)

 

GC

223 (43.3)

275 (36.2)

1.079 (0.723–1.609)

0.709

119 (41.2)

157 (36.3)

1.055 (0.626–1.779)

0.840

104 (46.0)

118 (36.2)

1.135 (0.608–2.118)

0.692

GG

236 (45.8)

420 (55.4)

1.557 (1.052–2.306)

0.026

138 (47.7)

236 (54.5)

1.368 (0.821–2.279)

0.227

98 (43.4)

184 (56.4)

1.878 (1.013–3.478)

0.043

CC + GC

279 (54.2)

339 (44.6)

1.0 (ref.)

 

151 (52.3)

197 (45.5)

1.0 (ref.)

 

128 (56.6)

142 (43.6)

1.0 (ref.)

 

GG

236 (45.8)

420 (55.4)

1.465 (1.170–1.834)

0.001

138 (47.7)

236 (54.5)

1.311 (0.973–1.767)

0.089

98 (43.4)

184 (56.4)

1.692 (1.202–2.383)

0.003

C

335 (32.5)

403 (26.5)

1.0 (ref.)

 

183 (31.7)

237 (27.4)

1.0 (ref.)

 

152 (33.6)

166 (25.5)

1.0 (ref.)

 

G

695 (67.5)

1115 (73.5)

1.334 (1.122–1.586)

0.001

395 (68.3)

629 (72.6)

1.230 (0.977–1.548)

0.078

300 (66.4)

486 (74.5)

1.483 (1.140–1.929)

0.003

rs2736100 (N)

515 (100%)

757 (100%)

  

289 (100%)

426 (100%)

  

226 (100%)

331 (100%)

  

AA

158 (30.7)

222 (29.3)

1.0 (ref.)

 

93 (32.2)

138 (32.4)

1.0 (ref.)

 

65 (28.8)

84 (25.4)

1.0 (ref.)

 

AC

257 (49.9)

364 (48.1)

1.008 (0.778–1.306)

0.952

136 (47.1)

201 (47.2)

0.996 (0.708–1.401)

0.982

121 (53.5)

163 (49.2)

1.042 (0.699–1.555)

0.839

CC

100 (19.4)

171 (22.6)

1.217 (0.884–1.676)

0.229

60 (20.7)

87 (20.4)

0.977 (0.641–1.489)

0.914

40 (17.7)

84 (25.4)

1.625 (0.989–2.670)

0.055

A

573 (55.6)

808 (53.4)

1.0 (ref.)

 

322 (55.7)

477 (56.0)

1.0 (ref.)

 

251 (55.5)

331 (50.0)

1.0 (ref.)

 

C

457 (44.4)

706 (46.6)

1.098 (0.934–1.284)

0.261

256 (44.3)

375 (44.0)

0.989 (0.799–1.223)

0.918

201 (44.5)

331 (50.0)

1.249 (0.982–1.588)

0.070

  1. GN Glomerulonephritis, CKD chronic kidney disease, ESRD end-stage renal disease, M male, F female, CI confidence interval; italic P value: statistically significant